SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA- versus vector-based vaccination in the general Dutch population
View ORCID ProfileLotus L. van den Hoogen, Marije K. Verheul, View ORCID ProfileEric R.A. Vos, Cheyenne C.E. van Hagen, Michiel van Boven, Denise Wong, Alienke J. Wijmenga-Monsuur, Gaby Smit, Marjan Kuijer, Debbie van Rooijen, Marjan Bogaard-van Maurik, Ilse Zutt, Jeffrey van Vliet, Fiona R.M. van der Klis, Hester E. de Melker, Robert S. van Binnendijk, View ORCID ProfileGerco den Hartog
doi: https://doi.org/10.1101/2021.10.25.21265467
Lotus L. van den Hoogen
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Marije K. Verheul
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Eric R.A. Vos
2Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Cheyenne C.E. van Hagen
2Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Michiel van Boven
2Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Denise Wong
2Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Alienke J. Wijmenga-Monsuur
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Gaby Smit
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Marjan Kuijer
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Debbie van Rooijen
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Marjan Bogaard-van Maurik
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Ilse Zutt
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Jeffrey van Vliet
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Fiona R.M. van der Klis
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Hester E. de Melker
2Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Robert S. van Binnendijk
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Gerco den Hartog
1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 26, 2021.
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA- versus vector-based vaccination in the general Dutch population
Lotus L. van den Hoogen, Marije K. Verheul, Eric R.A. Vos, Cheyenne C.E. van Hagen, Michiel van Boven, Denise Wong, Alienke J. Wijmenga-Monsuur, Gaby Smit, Marjan Kuijer, Debbie van Rooijen, Marjan Bogaard-van Maurik, Ilse Zutt, Jeffrey van Vliet, Fiona R.M. van der Klis, Hester E. de Melker, Robert S. van Binnendijk, Gerco den Hartog
medRxiv 2021.10.25.21265467; doi: https://doi.org/10.1101/2021.10.25.21265467
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA- versus vector-based vaccination in the general Dutch population
Lotus L. van den Hoogen, Marije K. Verheul, Eric R.A. Vos, Cheyenne C.E. van Hagen, Michiel van Boven, Denise Wong, Alienke J. Wijmenga-Monsuur, Gaby Smit, Marjan Kuijer, Debbie van Rooijen, Marjan Bogaard-van Maurik, Ilse Zutt, Jeffrey van Vliet, Fiona R.M. van der Klis, Hester E. de Melker, Robert S. van Binnendijk, Gerco den Hartog
medRxiv 2021.10.25.21265467; doi: https://doi.org/10.1101/2021.10.25.21265467
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (203)
- Cardiovascular Medicine (2955)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12768)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4602)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2935)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (927)
- Medical Education (428)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4379)
- Nursing (237)
- Nutrition (640)
- Oncology (2280)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1198)
- Primary Care Research (499)
- Public and Global Health (6967)
- Radiology and Imaging (1536)
- Respiratory Medicine (916)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)